Table 2.
Baseline patient characteristics at trial entry
| Intervention n = 31 |
Control n = 25 |
Total n = 56 |
|
|---|---|---|---|
| Mean age (SD) | 76.5 (3.7) | 76.4 (5.2) | 76.4 (4.4) |
| Number of prescribed medicationsa mean (SD) | 6.8 (1.9) | 6.6 (2.1) | 6.7 (2.0) |
| Medical conditions (current or previous)bn (%) | |||
| Cardiovascular | 19 (61.3) | 23 (92.0) | 42 (75.0) |
| Central nervous | 2 (6.5) | 5 (20.0) | 7 (12.5) |
| Gastro-intestinal | 6 (19.4) | 3 (12.0) | 9 (16.1) |
| Respiratory | 4 (12.9) | 2 (8.0) | 6 (10.7) |
| Ocular | 1 (3.2) | 1 (4.0) | 2 (3.6) |
| Urogenital | 9 (29.0) | 3 (12.0) | 12 (21.4) |
| Endocrine | 9 (29.0) | 3 (12.0) | 12 (21.4) |
| Musculoskeletal | 8 (25.8) | 7 (28.0) | 15 (26.8) |
| Other | 17 (54.8) | 10 (40.0) | 27 (48.2) |
| Allergy/intolerancecn (%) | |||
| Yes | 9 (29.0) | 8 (32.0) | 17 (30.4) |
| No | 22 (71.0) | 17 (68.0) | 39 (69.6) |
aWhen the same drug was recorded twice with two different or two of the same doses, this counted as one medication
bNumber of patients with at least one condition within each category
cNumber of patients with at least one allergy